Pertonitis Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

  • Published : Mar 2020
  • Report Code : KSI061611410
  • Pages : 114
excel pdf power-point

Pertonitis Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments.

Peritonitis Pipeline Analysis report covers 12 drugs currently in different phases of development. Perironitis is inflammation of the peritoneum. Peritoneum is the tissue lining the inner wall of the abdomen and internal organs such as kidneys and liver. It may be caused due to bacterial or fungal infections, a burst appendix or stomach ulcer, surgery or injury to the stomach. Symptoms include abdominal pain or tenderness, loss of appetite, fever, nausea and vomiting, diarrhoea, fatigue, low urine output and difficulty to pass stool. Diagnosis is done through blood tests, imaging and peritoneal fluid analysis.

The report provides peritonitis treatment drugs by company, phases of development including products in early discovery stage and NDA filing, molecule type, route of administration and region. The report will help to evaluate the collaboration, in-licensing and out-licensing opportunities, formulating business development strategies and tracking the activities of the key market players. Epidemiology, major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented to offer stakeholders a better understanding of the key factors affecting the overall market environment. Diagnosis of the disease is done through Skin biopsy for immunofluorescent mapping, Genetic testing and prenatal testing.

Various databases (for patents and Clinical Trials), studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the market.

Major industry players profiled as part of the report include Adenium Biotech, Biotest AG and Vascular Biogenics among others.

Scope:

By Company

By Phase

By Molecule Type

By Region

By Route of Administration

1. Introduction
1.1. Research Methodology
1.2. Research Scope
1.2.1. Analysis by Company
1.2.2. Analysis by Phase
1.2.3. By Molecule Type
1.2.4. By region
2. Disease Overview
2.1.1. Introduction
2.1.2. Classification
2.1.3. Symptoms
2.1.4. Causes
2.1.5. Diagnoses
2.1.6. Treatment
2.1.7. Epidemiology
3. Executive Summary
4. Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunities
5. Pipeline Analysis/Outlook
5.1. Analysis by Company
5.2. Analysis by Phase
5.2.1. Phase of Development
5.2.1.1. Introduction
5.2.1.1.1. Drug Profiling
• Drug Name
• Generic Name
• Synonyms
• Company
• Collaborator
• Route of administration
• Target 
• Mechanism of Action
• Technology
• Molecule type
• CAS Number
• Weight
• Chemical Formula
• IUPAC name
• ATC code
5.2.1.1.2. Strategic Developments
5.2.1.1.3. Clinical trials
5.2.1.1.4. Clinical trial results
5.2.1.1.5. Patents
5.2.1.1.6. Technology
5.2.2. Comparative Analysis for Trials by Phase (Pie, Bar graph)
5.3. By Molecule type
5.4. Analysis by Region
6. Company profiling
6.1. Adenium Biotech
6.1.1. Introduction
6.1.2. Financials
6.1.3. Products and Services
6.1.4. SWOT
6.2. Alopexx Vaccine, LLC
6.2.1. Introduction
6.2.2. Financials
6.2.3. Products and Services
6.2.4. SWOT
6.3. Aronora Inc.
6.3.1. Introduction
6.3.2. Financials
6.3.3. Products and Services
6.3.4. SWOT
6.4. Atox Bio
6.4.1. Introduction
6.4.2. Financials
6.4.3. Products and Services
6.4.4. SWOT
6.5. Biotest AG
6.5.1. Introduction
6.5.2. Financials
6.5.3. Products and Services
6.5.4. SWOT
6.6. ExeGi Pharma
6.6.1. Introduction
6.6.2. Financials
6.6.3. Products and Services
6.6.4. SWOT
6.7. Reponex Pharmaceuticals ApS 
6.7.1. Introduction
6.7.2. Financials
6.7.3. Products and Services
6.7.4. SWOT
6.8. SynAct Pharma AB
6.8.1. Introduction
6.8.2. Financials
6.8.3. Products and Services
6.8.4. SWOT
6.9. TAXIS Pharmaceuticals Inc
6.9.1. Introduction
6.9.2. Financials
6.9.3. Products and Services
6.9.4. SWOT
6.10. Vascular Biogenics
6.10.1. Introduction
6.10.2. Financials
6.10.3. Products and Services
6.10.4. SWOT
6.11. Veru Inc.
6.11.1. Introduction
6.11.2. Financials
6.11.3. Products and Services
6.11.4. SWOT
6.12. Zytoprotec
6.12.1. Introduction
6.12.2. Financials
6.12.3. Products and Services
6.12.4. SWOT
Adenium Biotech
Alopexx Vaccine, LLC
Aronora Inc.
Atox Bio
Biotest AG
ExeGi Pharma
Reponex Pharmaceuticals ApS 
SynAct Pharma AB
TAXIS Pharmaceuticals Inc
Vascular Biogenics
Veru Inc.
Zytoprotec

Related Reports

Report Name Published Month Download Sample
Pipeline Security Market Size & Forecast 2025-2030 | Free Sample Mar 2025
Hemochromatosis (Iron Overload) Pipeline Analysis 2018 (Q1) | Industry Report | Forecasts till 2024 Mar 2020
Merkel Cell Carcinoma Pipeline Analysis 2019 (H1) Mar 2020
Eosinophilic Esophagitis Pipeline Analysis 2019 (H1) Mar 2020
Gaucher Disease Pipeline Analysis 2018 (Q1) | Industry Report | Forecasts till 2024 Mar 2020